Literature DB >> 28450897

Plasma exchange as a cost-effective option for treating Guillain-Barré syndrome.

Eric J Buenz1, Gareth J Parry2, Annemarei Ranta3.   

Abstract

Entities:  

Year:  2016        PMID： 28450897      PMCID： PMC5400150          DOI： 10.1177/1756285616659978

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN： 1756-2856            Impact factor:   6.570


× No keyword cloud information.
  7 in total

1.  Resource implications of a national health target: The New Zealand experience of a Shorter Stays in Emergency Departments target.

Authors:  Peter Jones; Elizaveta Sopina; Toni Ashton
Journal:  Emerg Med Australas       Date:  2014-10-23       Impact factor: 2.151

2.  A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.

Authors:  Khaled Saad; Ismail L Mohamad; Mohamed A Abd El-Hamed; Mostafa S K Tawfeek; Ahmed E Ahmed; Khaled A Abdel Baseer; Ahmed S El-Shemy; Amira A El-Houfey; Diaa M Tamer
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

Review 3.  Plasma exchange for Guillain-Barré syndrome.

Authors:  Jean Claude Raphaël; Sylvie Chevret; Richard A C Hughes; Djillali Annane
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

4.  Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis.

Authors:  Julio C Furlan; David Barth; Carolina Barnett; Vera Bril
Journal:  Muscle Nerve       Date:  2015-11-26       Impact factor: 3.217

Review 5.  Intravenous immunoglobulin for Guillain-Barré syndrome.

Authors:  Richard A C Hughes; Anthony V Swan; Pieter A van Doorn
Journal:  Cochrane Database Syst Rev       Date:  2014-09-19

6.  Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome.

Authors:  Jeffrey L Winters; David Brown; Elisabeth Hazard; Ashok Chainani; Chester Andrzejewski
Journal:  BMC Health Serv Res       Date:  2011-05-16       Impact factor: 2.655

7.  Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study.

Authors:  Mohammed A El-Bayoumi; Ahmed M El-Refaey; Alaa M Abdelkader; Mohamed M A El-Assmy; Angi A Alwakeel; Hanem M El-Tahan
Journal:  Crit Care       Date:  2011-07-11       Impact factor: 9.097
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.